Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grimont, P. A. D., Grimont, F., Farmer, J. J., & Asbury, M. A. (1981). Cedecea davisae gen. nov., sp. nov. and Cedecea lapagei sp. nov., New Enterobacteriaceae from Clinical Specimens. International Journal of Systematic Bacteriology, 31(3), 317–326.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, and clinical sources
DNA G+C(%): 49-50
|
Opt. T: 37℃
Low T(℃): 5(+)
Mid T(℃): 40(neg)
NaCl 0.5-2%: 0(+)
NaCl >6%: 6(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: Res
carbenicil: Sens
penicillin: Res
|
cefuroxime: Res
cephalothin: Res
|
amikacin: Sens
gentamicin: Sens
kanamycin: Sens
streptomycin: Sens
tobramycin: Sens
|
telithromycin: Sens
|
ciprofloxacin: S(clinic,500)
nalidixic-acid: Sens
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
minocycline: Sens
tetracycline: Sens
|
|
|
chloramphenicol: Sens
metronidazole: S(clinic,500)
nitrofurantoin: Sens
sulfadiazine: Sens
trimethoprim: Sens
|
colistin: Res
polymyxin_B: Res
vibriostat_129: Sens
|